Press Release
Sep 09, 2023
Media Contact: Chris Martin, MPH, IASLC Media Relations, 630.670.2745, cmartin@davidjamesgroup.com
[Singapore Sept. 9, 2023] — The International Association for the Study of Lung Cancer awarded Massachusetts General Hospital in Boston, Mass., and New York Oncology Hematology in Albany, N.Y., from North America with one of the association’s most prestigious awards—the IASLC Cancer Care Team Award (CCTA) during the IASLC 2023 World Conference on Lung Cancer.
The CCTA recognizes a single institution in North America, Europe, Latin America, and Asia/the Rest of the World that provides exceptional care for patients with lung cancer and thoracic malignancies.
Teams are nominated by patients, survivors, caregivers, partners, and family members. A nomination can include up to six individuals from the care team (e.g., oncologist, surgeon, nurse, palliative care provider, etc.). Nominations are accepted from all around the world.
North America Regional Winner – Massachusetts General Hospital in Boston, Mass., and New York Oncology Hematology in Albany, N.Y.
Jessica Lin, MD/Medical Oncologist, Lead nominee
Nancy Wang, MD/Neuro-Oncologist
Helen Shih, MD/Radiation Oncologist
Makenzi Evangelist, MD/Medical Oncologist, New York Oncology Hematology
Peggy Leland, RN/Nurse Practitioner
Asia/ROW Regional Winner – Yonsei Cancer Center, Yonsei University in Seoul, Republic of Korea (South Korea)
Byoung Chul Cho, MD, PhD/Medical Oncologogist, Lead Nominee
Chang Young Lee, MD, PhD/Thoracic Surgeon
Sun Min Lim, MD, PhD/Medical Oncologist
Jeong Eun Choi, RN/Nurse Coordinator
Jin Gu Lee, MD, PhD/Thoracic Surgeon
Hong In Yoon, MD, PhD/Radiation Oncologist
Latin America Regional Winner – Oncosalud – AUNA in Lima, Peru
Rossana Ruis, MD/Medical Oncologist, Lead nominee
Luis Mas, MD/Medical Oncologist
Victor Rojas, MD/Thoracic Surgeon
Julio Velasquez, MD/Radiologist
Brend Carrion, MD/Radiation Oncologist
Katherine Gutarra, MD/Pulmonolgist
Europe Regional Winner – Medical University of Gdańsk in Gdańsk, Poland
Witold Rzyman, MD, PhD/Thoracic Surgeon, Lead nominee
Rafal Dziadziuszko, MD/ Medical Oncologist
Katarzyna Dziadziuszko, MD/Lung Cancer Screening Radiologist – Program Coordinator
Iwona Biadacz, RN/Nurse Practitioner, University Clinical Center, Gdansk
Joana Bidzińska, MD/Oncologist Coordinator
Edyta Szurowska, MD/Radiologist
###
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The goal is to increase awareness, collaboration, and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2023.iaslc.org/